WeedLife News Network

In spite of ever-growing support for marijuana use in the United States, a recently-released FBI report revealed there were more people arrested for cannabis last year than for all violent crimes together. 

According to data from the Uniform Crime Report, a total of 545,602 people were arrested in the U.S. for marijuana-related offenses in 2019. However, the same report showed 495,871 people were arrested for violent crimes last year throughout the country. 

What’s even more interesting is the fact that 92% of the people arrested for cannabis, or 500,395, were apprehended for the mere possession of marijuana – which has been decriminalized in 28 U.S. states to date.  Eleven states have fully legalized marijuana, while a number of others allow cannabis for medical use.

The majority of the drug arrests were made in the Northeastern U.S., while in the Western U.S., where cannabis is largely legal, marijuana arrests were much less frequent. 

“Police across America make a marijuana-related arrest every 58 seconds. At a time when the overwhelming majority of Americans want cannabis to be legal and regulated, it is an outrage that many police departments across the country continue to waste tax dollars and limited law enforcement resources on arresting otherwise law-abiding citizens for simple marijuana possession,” Executive Director for cannabis advocacy group NORML Eric Altieri said following the release of the FBI data.  

The US Hemp Roundtable, the hemp industry’s leading national advocacy organization, is profoundly disappointed that the California Senate leadership refused to allow a vote on AB 2028 (Aguiar-Curry, Wicks and Wilk), which would have legalized the use of hemp CBD in all products, to advance before the end of the 2019-20 legislative session.

As a result, California will not benefit from tens of millions of new tax dollars or thousands of new jobs that AB 2028 would have delivered. California continues to lag behind 21 other states, including Florida, Texas, Virginia and Ohio, that have already enacted hemp CBD laws and are drawing business away from California.

AB 2028 represented the product of intense negotiations between the Roundtable, its allies in the California hemp farming and business industries, and Governor Gavin Newsom, an effort that legislative leaders had urged proponents to undertake. The measure received broad bipartisan support as evidenced by its passage in an earlier bill with unanimous votes by the Assembly, as well as the Senate Health and Business and Professions Committees.

“We have been told by staff to Senate President Pro Tem Toni Atkins that there simply was not enough time to consider the amendments to the bill in the waning days of session,” said Jonathan Miller, the Roundtable’s general counsel. “Assuming that is the case, we are optimistic that a reintroduction of AB 2028 at the earliest possible date, with any necessary technical fixes, will ultimately be supported by both houses of the Legislature and signed by Governor Newsom.”

As a result of the COVID-19 pandemic, the California economy is profoundly distressed. Tax revenues have been hard hit, jobs have disappeared and the ability of the state to rebuild itself in a timely fashion is uncertain. The hemp industry, especially its hemp CBD market, represents a major source of new state and local revenues that can be realized quickly.

National market analyses (Brightfield Group and Fortune Business Insights, among others) project that the hemp CBD food and beverage industry alone will generate more than $2 billion annually by 2023. If enacted, AB 2028 would have pegged California’s share of that market at approximately $300 million in the first full year of operation.

Mexico is one of the most exciting emerging cannabis markets in the world and we believe that the market is nearing an inflection point. Recently, we came across studies that highlighted the potential of the Mexican cannabis market and this is an opportunity that we are excited about over the long-term.w

In 2017, after a separate Supreme Court mandate, then-President Enrique Peña Nieto signed a decree legalizing cannabis for medical use. The government has stalled in implementing necessary regulations, and the drug remains out of reach for many patients. Almost two years ago, Mexico’s Supreme Court ruled that a cannabis ban as unconstitutional and we are favorable on how the topic has been gaining support.

The support that is being shown for the cannabis industry comes ahead of a key date for Mexico’s cannabis market. Under orders from the Supreme Court, Mexican lawmakers have until December 15th to pass cannabis legislation.

Although we are surprised with the amount of time it has taken to advance the Mexican cannabis market, the development is a great example of how much the world has changed over the last few decades. Previously, Mexico had restrictive drug laws that was fueled by deadly cartels wars and we are favorable on the way the industry is trending.

Currently, there is an intense debate on what legalization should look like and whom it should benefit. One side of the group believes that domestic cultivators that are currently cultivating cannabis should be protected from competition from large international cannabis companies. Recently, a bill was introduced that would allow private companies to sell cannabis to the public. Senate leader Ricardo Monreal expects the legislation to pass in the Senate within two weeks and then go to the lower house of Congress.

Voters in New Zealand will vote on Saturday on a nationwide referendum that would legalize the use and possession of cannabis by those 20 years of age and older. If passed, the vote would make New Zealand only the third country worldwide to legalize cannabis at the national level, joining Uruguay and Canada.

The referendum, known as the Cannabis Legalisation and Control Bill, would require the New Zealand Parliament to establish rules and regulations for the commercial production and sale of cannabis and cannabis-infused products. The measure would also permit adults at least 20 years old to purchase up to 14 grams of herbal cannabis per day. Home cultivation of up to four cannabis plants per household would also be allowed under the ballot measure. Under current New Zealand law, the use of marijuana by adults is a crime punishable by up to three months in jail.

Last week, a group of New Zealand’s leading public health professionals expressed their support for the legalization referendum in an editorial published in the New Zealand Medical Journal.  Professor Michael Baker of the University of Otago, one of the health experts who helped guide New Zealand’s response to the COVID-19 pandemic, said that the country is a world leader in using “innovative and evidence-informed approaches” to addressing complicated public health issues.

“It’s time to take the same fresh approach to cannabis law and put public health first,” Baker said.

“Our prohibition model for cannabis is outdated and doesn’t work,” Baker added. “Supporting law reform is about reframing cannabis use as a health issue which opens up new, more effective ways of minimizing harms caused by this drug.”

Legalizing marijuana could help Pennsylvania weather the economic turbulence brought on by the COVID-19 pandemic.

That was the argument put forth on Tuesday by the state’s governor, Tom Wolf, who continued to urge Keystone State lawmakers to take up the issue.

“This year, I again went to the General Assembly and asked them to make legalizing adult-use cannabis a priority for the fall as we work to find ways to overcome the economic hardships of the COVID-19 pandemic. To date, there has been no movement to advance legislation,” Wolf said during a morning visit to Monroe County, Pennsylvania, as quoted by local television station WGAL.

According to the station, Wolf likened the legalization of recreational pot to the “economic growth that the historic farm bill of 2018 did for hemp farming after decades of prohibition.”

That farm bill prompted many states to establish their own rules for hemp cultivation, with local farmers eager to capitalize on the CBD boom in recent years.

Last week, the cannabis sector rallied after Kamala Harris’ debate with Vice President Mike Pence. We believe the reason for the move higher is related to Harris stating that cannabis would be decriminalized under a Joe Biden administration.

In late 2019, Pew Research Center conducted a survey that found that two-thirds of Americans believe that cannabis should be legal. The survey also found that there has been a significant decline in the number of adults who believe that cannabis should be illegal. According to the survey, the percentage of adults who oppose the legalization of cannabis has fallen from 52% in 2010 to 32%.

Numbers do not lie, and the American people want cannabis to be legalized. The COVID pandemic put considerable pressure on the global economy and the US economy was not immune to this. States desperately need money and are looking for additional revenue streams in a post-pandemic world.

As it relates to economies (state and federal) finding new revenue streams, the legalization of sports betting was the first domino to fall. The change in regulation has been a catalyst for the US economy (and stock market) and several sports betting companies have recently gone public and are valued at more than $50 billion in aggregate (Draft Kings and Penn National Gaming).

We believe that the legalization of cannabis would prove to be an even larger taxable revenue stream than sports betting. States need more revenue and we expect cannabis to draw new voters to the polls and play an important role in the outcome of the November election.

Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even CBD.

The National Psoriasis Foundation states that upwards of 8 million people have the auto-immune skin disorder. Often accompanied by arthritis, psoriasis not only causes scaling of the skin, but complications to fingernails as well. 

Affecting everyone from children to adults, psoriasis can lead to anxiety and depression, as individuals with the skin disorder are often afraid of being ridiculed. Usually treated with Humira and Enbrel, psoriasis comes with a shocking price tag and complications that are often difficult to ignore. 

A 2014 study published in the journal Drugs in Context found that Humira had a price tag upwards of $39,000, while Enbrel’s annual cost was around $46,000. Stelara, the most expensive drug, was found to cost over $53,000. As TNF blockers, while medications like Humira help against psoriasis, they can lower the body’s ability to fight infections and cause serious side effects. 

Even more interesting, a September 2019 study in London found that, “A number of medications commonly prescribed by rheumatologists may interact with cannabidiol oil” (CBD oil). The most affected medicines appear to be corticosteroids (including hydrocortisone and prednisolone) since CBD, “is a potent inhibitor of CYP3A.” Put plainly, CBD may block the effects of the other medicine. 

With just 21 days till voters in New Jersey get to decide on whether to legalize recreational marijuana in their state, a majority of them appear to be in favor of the measure, according to a new poll. 

Released last week by Fairleigh Dickinson University, the poll was conducted from September 30 through October 5 and included 582 randomly selected likely voters in the Garden State. Sixty-one percent of those surveyed said that they support legalization, while only 29% said they will vote against the measure.

Among Democrats, 71% of those contacted said they will vote yes on November 3. On the other hand, the percentage of Republicans that would support legalization was reported at 52%. 

New Jersey Governor Phil Murphy has made cannabis legalization a policy priority of his, but previous attempts to legalize cannabis via the state legislature have proven unsuccessful. Voters will instead decide on the matter on Election Day, when the country either re-elects President Donald Trump or chooses his opponent Joe Biden to lead the U.S for the next four years. 

Recently, Murphy released a pro-legalization video, in which the governor urged New Jersey voters to end prohibition, underscoring that it costs taxpayers $150 million every year. 

New Jersey looks set to be the next state to legalize marijuana. It's on the ballot come Election Day on November 3, the polls are looking good, and while it's not the only state with marijuana legalization on the ballot, the others—Arizona, Montana, and South Dakota—are all out West, and the Garden State should beat them by a few hours.

The New Jersey legalization initiative, Public Question 1, would amend the state constitution to legalize the recreational use of marijuana and its cultivation, processing, and retail sale by a person who is at least 21 years old. It also designates the existing Cannabis Regulatory Commission (CRC), which currently handles medical marijuana, to regulate all legal marijuana commerce. Retail marijuana sales would be subject to the state sales tax of 6.625 percent, but any other state sales taxes would be prohibited. The initiative authorizes the legislature to let local governments add a 2 percent local sales tax.

It also leaves it up to the legislature and the CRC to address unresolved issues. Those include whether and how home cultivation would be allowed, how much weed people could possess, and detailed retail regulations.

If the measure passes, New Jersey will not only be the first to legalize marijuana this Election Day, it will also be the first mid-Atlantic state to do so, and the first to legalize it via a legislatively initiated voter referendum. Of the 11 states (and the District of Columbia) that have so far legalized marijuana, nine did it through citizen-based ballot initiatives, while in the other two, Illinois and Vermont, legislatures passed legalization bills.

Vermont has become the latest U.S. state to legalize cannabis sales after Governor Phil Scott allowed a new marijuana commercialization bill to take effect without his signature. 

In the run-up to his announcement, there was speculation the Vermont governor could even veto the bill, which passed the state legislature last month. Governor Scott was reluctant to sign the legislation over several concerns regarding driving under the influence of cannabis and vaping products, and what he feels as a lack of social equity provisions in the new bill.

With this move, Vermont became the 11th state to tax and regulate marijuana sales and the second to approve it via state legislature. 

“There is still more work to be done to ensure the health and safety of our kids and the safety of our roadways, we should heed the public health and safety lessons of tobacco and alcohol. Further, I believe we are at a pivotal moment in our nation’s history which requires us to address systemic racism in our governmental institutions. We must take additional steps to ensure equity is a foundational principle in a new market,” the governor wrote to lawmakers.

He added that the concerns of communities disproportionately targeted by the so-called War on Drugs were not adequately addressed in the legislation.

Issuing of the first commercial licence for growing industrial hemp in Australia’s Northern Territory was announced on Friday – and it’s been a long time coming.

The successful licensee is Michael Jakobi:

“I applied for a commercial hemp licence because I wanted an alternative to growing hay and because I thought it would be a good rotational fit with some of my crops,” said Mr. Jakobi. “The fact that hemp is multi-use is very appealing, I am also interested in the possible soil conditioning benefits planting hemp may have for my future crops.”

The Northern Territory Government seems pretty pumped about the prospects for local production of hemp.

“To grow our economy, we need to diversify our economy – and expanding into the exciting sector of industrial hemp does just that,” said Minister for Agribusiness and Aquaculture Nicole Manison. “Starting an industrial hemp industry here in the Territory brings with it new jobs and new manufacturing and exporting opportunities – the potential is very exciting.”

As it stands right now there are only two countries on earth that have passed an adult-use cannabis legalization measure.

The first to ever do it was Uruguay in 2013.

Uruguay’s legalization model is somewhat limited in that only residents can legally purchase adult-use cannabis.

Canada became the first G-7 nation to legalize cannabis for adult-use when it passed a nationwide legalization measure in 2018. 

The legalization model in Canada is such that any legally aged adult from anywhere on the planet can come to Canada and make a legal adult-use cannabis purchase.

In a case that could have a dramatic impact on the state’s pot industry, the Florida Supreme Court made the unusual move Wednesday of hearing a second round of arguments in a challenge to a state law aimed at implementing a constitutional amendment that broadly legalized medical marijuana.

Tampa-based Florigrown LLC is challenging the 2017 law, which created a regulatory structure for the state’s medical marijuana industry. Florigrown, whose owners include prominent strip-club operator Joe Redner, alleges that the law improperly carries out the amendment.

One part of the law requires medical marijuana operators to handle all aspects of the cannabis business, including growing, processing, distributing and selling products. But Florigrown maintains the requirement, known as a “vertical integration” system, runs afoul of the constitutional amendment, approved by more than 71% of voters in 2016. The vertical integration requirement limits the number of companies that can participate in the industry, the Tampa business contends.

Florigrown won in lower courts after initiating its legal challenge three years ago. Wednesday’s arguments came after Gov. Ron DeSantis’ administration appealed an appellate-court decision that upheld part of a temporary injunction issued by Leon County Circuit Judge Charles Dodson, who found that the 2017 law conflicted with the constitutional amendment.

The Supreme Court heard arguments in the case in May but, in a rare move, ordered a new round of arguments focused on whether the statute equates to an unconstitutional “special law.” The Florida Constitution bars “special” laws, which, generally, are intended to benefit specific entities.

Nearly 50 pieces of cannabis legislation have been introduced during the 2019-2020 legislative session of the U.S. Congress. These various bills, amendments, resolutions and laws represent a busy year for marijuana activity on Capitol Hill. While many have been introduced, much remains the same. With only the House of Representatives appearing remotely close to voting on anything, cannabis regulations aren’t likely to move at all before Election Day 2020. 

That said, several pieces of legislation could advance rules in critical areas from law enforcement to access. Sources tell High Times that of the proposed pieces of legislation, two stand out among the rest for their ability to influence America.

The SAFE Banking Act 

H.R.1595, better known as the Secure And Fair Enforcement (SAFE) Banking Act of 2019, was for some time in 2020, the most discussed and likely to pass piece of legislation cannabis has seen in ages. 

If passed, the bill would provide protections to banks, allowing institutions to work with the cannabis industry without fear of federal repercussions. The bill provides assurance to marijuana and hemp operators who continually face rejections from banks. Even when accepted as a customer, numerous operators have found their accounts shut down once the bank became aware of the operator’s business. 

Hans Enriquez, CEO of Dazed Inc. cannabis brand, stated that the SAFE Banking Act would be the most substantial piece of legislation for the industry. Enriquez highlighted the cannabis industry’s ability to bank like any other industry as the most substantial bill aspect. 

Most of us like to believe that scientific inquiry is governed by a spirit of curiosity and neutrality, investigating the subject of study from every possible angle. Unfortunately, when it comes to cannabis research in the United States, the approach has been largely one-sided.

According to a new analysis of cannabis research funding in the US, Canada, and the UK, about $1.56 billion went toward cannabis research between 2000 and 2018. Roughly half of that funded research focused on the potential harms of cannabis.

Individual years proved even worse. For example, in 2018, research on potential harms of cannabis received more than 20 times more funding than research on cannabis therapeutics.

What’s more, the biggest chunk of the money (about $1 billion) came from the U.S. National Institute on Drug Abuse (NIDA), a federal government agency. According to the analysis, NIDA put far more money to research cannabis misuse and its adverse effects than on the therapeutic potential of cannabis.

“The government’s budget is a political statement about what we value as a society,” Daniel Mallinson, a cannabis policy researcher at Pennsylvania State University, Harrisburg, told Science Magazine. “The fact that most of the cannabis money is going to drug abuse and probably to cannabis use disorder versus medical purposes—that says something.” 

The coronavirus pandemic took a significant toll on New York, affecting the state and its residents physically, emotionally and financially. Through adherence to public health protocols, we have gone from being the epicenter of the outbreak to having some of the nation’s lowest infection and fatality rates.

Hopefully we will continue this trajectory. On the financial side, however, we have not even begun to assess the full extent of the damage. The state faces a staggering $14.5 billion budget shortfall this year alone and a projected $62 billion decline through FY 2024 due to COVID-19. Even if Congress and the White House pass a new stimulus package, whatever New York receives will not come close to filling its need

Hawaii will adopt a federal industrial hemp production program at the end of this month, signaling the end of the state’s two-year-long Industrial Hemp Pilot Program.

However, the changing programs have hemp farmers worried, with concerns that growing hemp will no longer be economically viable under the federal program.

Thanks to a bill passed by the state Legislature during the last session and signed into law by Gov. David Ige, the state legalized the growth of hemp throughout the state via the U.S. Department of Agriculture’s hemp production program. But while this bill ostensibly removed roadblocks for farmers seeking a license to grow hemp, farmers under the pilot program believe the USDA program is significantly more restrictive.

“I know some farmers are just waiting to see what happens before they apply at all,” said Gail Baber, a Big Island hemp grower who was one of the first in the state to be licensed through the pilot program.

While Shelley Choy, coordinator of the pilot program, said the federal program has much less stringent requirements for applications — being a program for commercial growers, rather than a research program as the pilot program is — Baber said the one-size-fits-all nature of the federal program has led to some serious concerns with how the program will be enforced.